Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
Author:
Affiliation:
1. Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
2. Human Technopole, Milan, Italy
Funder
Fondazione Ricerca Molinette
Italian Association for Cancer Research
AIRC/FIRC
Università degli Studi di Torino
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2086752
Reference71 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2. SEOM clinical guidelines in early stage breast cancer (2018)
3. Updates on the treatment of invasive breast cancer: Quo Vadimus?
4. Chemoresistance mechanisms of breast cancer and their countermeasures
5. Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer;Gene;2024-11
2. Participation of TLRs in cancer immunopathogenesis and drug resistance via interacting with immunological and/or non-immunological signaling pathways as well as lncRNAs;International Immunopharmacology;2024-10
3. Metadichol, a modulator that controls expression of Toll Like Receptors in Cancer Cell Lines;2024-08-19
4. Neutrophil extracellular trap related risk score exhibits crucial prognostic value in skin cutaneous melanoma, associating with distinct immune characteristics;Skin Research and Technology;2024-08
5. Toll-like receptors in breast cancer immunity and immunotherapy;Frontiers in Immunology;2024-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3